Clinical Trials Insight: 700021667
Latest Information Update: 13 Sep 2007
At a glance
- Drugs NGX 267 (Primary)
- Indications Alzheimer's disease; Cognition disorders
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors TorreyPines Therapeutics Inc
- 10 Sep 2007 Status change from initiated to completed
- 15 Mar 2007 New trial record.